Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

Some individuals may experience shingles or chickenpox-like rashes within 42 days after receiving zoster vaccine. Transmission of VZV virus from vaccinated individuals to other individuals occurs rarely.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Powder for Injection: 0.65 ml

STORAGE: Powder should be stored frozen at 15 C (5 F) or colder until ready to use. Diluent should be stored at room temperature (20 C - 25 C [68 F - 77 F]) or refrigerated at (2 C - 8 C [36 F - 46 F]).

DOSING: Zoster vaccine is injected subcutaneously (under the skin) in the upper arm. The recommended dose is 0.65 ml.

DRUG INTERACTIONS: In clinical studies, concomitant use of zoster vaccine and Pneumovax reduced the activity of zoster vaccine.

PREGNANCY: Zoster vaccine is not used for preventing shingles in women of child bearing age and should not be administered to pregnant women.

NURSING MOTHERS: Zoster vaccine is not used for preventing shingles in nursing mothers.

Medically reviewed by Eni Williams, PharmD

Reference: FDA Prescribing Information for Zostavax


Medically Reviewed by a Doctor on 3/30/2015


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index